INZY,Inozyme Pharma, Inc. | Healthcare

Healthcare

INZY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Inozyme Pharma, Inc.INZY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

56.91M

Revenue (ttm)

n/a

Net Income (ttm)

-102.02M

Shares Out

64.24M

EPS (ttm)

-1.62

PE Ratio

n/a

Forward PE

n/a

Dividend

n/a

Ex-Dividend Date

n/a

Volume

185,724

Open

0.8800

Previous Close

0.8807

Day's Range

0.8319 - 0.9015

52-Week Range

0.7210 - 6.2400

Beta

1.39

Analysts

Strong Buy

Price Target

17.22 (+1,843.79%)

Earnings Date

May 6, 2025

Description >

Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States.

The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein, which is in Phase 1/2 clinical trials for the treatment of ENPP1 and ABCC6 deficiency, as well as for the treatment of calciphylaxis.

It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Latest News >

Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln

Jul 8, 2024

July 8 (Reuters) - Eli Lilly ( LLY ) will acquire Morphic Holding ( MORF ) for $3.2 billion, the companies said on Monday, giving the U.S. drugmaker access to an experimental drug for inflammatory bowel disease. Shares of drug developer Morphic ( MORF ) surged 76% to $56.15 premarket on Lilly's offer of $57 per share, which represents a...

Vista Outdoor Says Kinetic Group Purchase Price Raised by Czechoslovak Group to $2.1 Billion

Jul 8, 2024

07:03 AM EDT, 07/08/2024 (MT Newswires) -- Vista Outdoor ( VSTO ) said Monday that it entered an amendment to the merger agreement with Czechoslovak Group, increasing the purchase price for The Kinetic Group business by $100 million to $2.1 billion. The amendment also increases the cash consideration payable to Vista Outdoor ( VSTO ) stockholders by $3 per share...

Else Nutrition Raises US$2 Million Through Unit Offering

Jul 8, 2024

07:06 AM EDT, 07/08/2024 (MT Newswires) -- Else Nutrition Holdings ( BABYF ) over the weekend said it raised US$2 million selling 13.2 million units at US$0.151 per unit. Each unit consists of one Else Nutrition ( BABYF ) common share and one common share purchase warrant exercisable to acquire one common share at a price of US$0.151 until July...

Bitcoin miner Bitfarms taps insider Ben Gagnon for CEO role

Jul 8, 2024

July 8 (Reuters) - Canada-based bitcoin miner Bitfarms ( BITF ) said on Monday it has appointed insider Ben Gagnon as its new chief executive officer. ...